https://etira.life/wp-content/uploads/2026/01/Dr-Annalisa.jpg
500
500
Etira
https://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.png
Etira2026-01-09 08:00:542026-01-10 16:42:31Etira Board Member recognized in 2026 King’s New Year HonorsBreakthroughs that
See news releases about Etira, our stellar team,
https://etira.life/wp-content/uploads/2026/01/Dr-Annalisa.jpg
500
500
Etira
https://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.png
Etira2026-01-09 08:00:542026-01-10 16:42:31Etira Board Member recognized in 2026 King’s New Year Honors
Etira Founder’s Scientific Journey Highlighted
NewsSan Antonio, TX – November 18, 2025. Etira Founder Professor Ratna Vadlamudi delivered a compelling, deeply personal narrative as the featured speaker at the Health Cell State of the Industry event at the Tobin Center in San Antonio. He reflected…

Etira CEO Featured In Clinical Leader for R&D Efficiency
NewsPhiladelphia, PA – July 16, 2025: In an article just published in Clinical Leader magazine entitled "How An Australia-First Strategy Cut 63% From Our R&D Spend", Etira CEO Russell Hayward explains how our strategic decision to conduct…

Progress in ERX-315 Phase 1 Clinical Trial
NewsDallas, Texas — June 26, 2025: Etira, a clinical-stage biopharmaceutical company aiming to develop cancer therapies, announced today that the first patient has been successfully treated at Dose Level Four (DL4) in its ongoing Phase 1 clinical…

Etira Expands Clinical Trial Sites
NewsSydney, Australia – June 2, 2025: Etira, a clinical-stage biopharmaceutical company focused on developing cancer therapies, announced the activation of a new trial site at Macquarie University Hospital (MUH) in Sydney, New South Wales. The…

Research on Etira drugs win awards at AACR 2025
NewsChicago, IL – April 30, 2025:Presenters of two abstracts with preclinical data on ERX-208 and ERX-315 have won awards at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.Adriana Baker, who presented…


Where to find us
Dallas Office:
3033 Irving Blvd,
Dallas. TX. 75247
Mailing Address:
3060 Pegasus Park Dr.
Dallas. TX. 75247

